Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Long-Term-Liabilities" stands at 53.57 Billion Japanese Yens as of 03/31/2025, the highest value at least since 06/30/2019, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.41 percent compared to the value the year prior.
The 1 year change in percent is 9.41.
The 3 year change in percent is 36.53.
The 5 year change in percent is 106.03.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Liabilities | 280,205,508,085.11 |